Fahmita Karin Dhia, Ardiany Deasy
Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Ann Med Surg (Lond). 2022 Aug;80:104244. doi: 10.1016/j.amsu.2022.104244. Epub 2022 Jul 31.
Micropenis usually has a series of causative factors that must be identified to determine the treatment modality.
A 24-years-old Indonesian male complained of a small penis since infancy. The patient has a short penis size (3 cm), no pubic hair, small scrotum, both testes cannot hide palpable, and tanner scale 2. The hormonal examination includes testosterone hormone of 14.94 ng/dL, luteinizing hormone of 14.89 mUI/mL, and follicle-stimulating hormone of 67.51 mUI/mL. Ultrasound showed no testicular location and only a prostate-like appearance of a size of 0.6 × 2.07 cm on the abdomen. The patient will receive therapy but was constrained by the COVID-19 pandemic.
diagnosis of micropenis and gonadotropin hormone disorders must be detected early and receive treatment immediately for better results.
Micropenis is a medical diagnosis that depends on proper examination and management, and early diagnosis is essential to improve prognosis.
小阴茎通常有一系列致病因素,必须加以识别以确定治疗方式。
一名24岁的印度尼西亚男性自婴儿期起就抱怨阴茎短小。患者阴茎短小(3厘米),无阴毛,阴囊小,双侧睾丸无法触及, Tanner分期为2期。激素检查包括睾酮激素14.94纳克/分升、促黄体生成素14.89毫国际单位/毫升和促卵泡生成素67.51毫国际单位/毫升。超声检查未发现睾丸位置,腹部仅见一个大小为0.6×2.07厘米的类似前列腺的结构。患者将接受治疗,但受到新冠疫情的限制。
小阴茎和促性腺激素紊乱的诊断必须尽早发现并立即接受治疗,以取得更好的效果。
小阴茎是一种依赖于正确检查和管理的医学诊断,早期诊断对于改善预后至关重要。